Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patients

Kidney International

Volumn 85, Issue 1, 2014, Pages 151-157

  Mccafferty, Kieran ^a,b   Fan, Stanley ^a   Davenport, Andrew ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

bioimpedance; extracellular water; peritoneal dialysis; residual renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; COHORT ANALYSIS; EXTRACELLULAR FLUID; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; HYPERTENSION; IMPEDANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEASUREMENT; MIDDLE AGED; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; RESIDUAL RENAL FUNCTION; TOTAL BODY WATER;

AGED; BODY WATER; ELECTRIC IMPEDANCE; EXTRACELLULAR FLUID; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84891555254     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.273     Document Type: Article

References (40)

1. Maiorca R, Brunori G, Zubani R et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295-2305. (Pubitemid 26033447)
2. Bargman JM, Thorpe KE, Churchill DN et al. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162. (Pubitemid 32880353)
3. Wang AY, Wang M, Woo J et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62: 639-647. (Pubitemid 34779779)
4. Wang AY, Sea MM, Ip R et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 2450-2457. (Pubitemid 33021123)
5. Lopez-Menchero R, Miguel A, Garcia-Ramon R et al. Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron 1999; 83: 219-225. (Pubitemid 29486400)
6. Wang AY, Woo J, Wang M et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20: 396-403. (Pubitemid 40276898)
7. Wang AY, Woo J, Sea MM et al. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? Am J Kidney Dis 2004; 43: 712-720. (Pubitemid 38401887)
8. Wang AY, Lam CW, Wang M et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis 2005; 45: 715-729. (Pubitemid 40460760)
9. Huang WH, Chen KH, Hsu CW et al. Residual renal function - one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137.
10. Termorshuizen F, Korevaar JC, Dekker FW et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) -2. Am J Kidney Dis 2003; 41: 1293-1302. (Pubitemid 36637986)
11. Park HC, Lee H, Lee JP et al. Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients. J Korean Med Sci 2012; 27: 64-71.
12. Morinaga H, Sugiyama H, Inoue T et al. Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients. Perit Dial Int 2012; 32: 453-461.
13. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13: 962-968. (Pubitemid 28161772)
14. Diaz-Buxo JA, Lowrie EG, Lew NL et al. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 1999; 33: 523-534. (Pubitemid 29107030)
15. Lysaght MJ, Vonesh EF, Gotch F et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598-604.
16. Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053. (Pubitemid 35316736)
17. Bedogni G, Malavolti M, Severi S et al. Accuracy of an eight-point tactileelectrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002; 56: 1143-1148. (Pubitemid 35414802)
18. Liao CT, Shiao CC, Huang JW et al. Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients. Perit Dial Int 2008; 28: S191-S195.
19. Gunal AI, Duman S, Ozkahya M et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-593. (Pubitemid 32195299)
20. Gunal AI, Kirciman E, Guler M et al. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren Fail 2004; 26: 405-409. (Pubitemid 39167618)
21. Konings CJ, Kooman JP, Schonck M et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63: 1556-1563. (Pubitemid 36350022)
22. Papakrivopoulou E, Booth J, Pinney J et al. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra 2012; 2: 48-54.
23. Konings CJ, Kooman JP, Schonck M et al. Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002; 22: 683-692. (Pubitemid 36131498)
24. Chen W, Guo LJ, Wang T. Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients. Blood Purif 2007; 25: 260-266. (Pubitemid 47074639)
25. Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040.
26. Paniagua R, Amato D, Mujais S et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 2008; 3: 407-415.
27. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35-44. (Pubitemid 126506938)
28. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R et al. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44: 132-145. (Pubitemid 38880935)
29. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009; 29: 297-302.
30. Fan S, Sayed RH, Davenport A. Extracellular volume expansion in peritoneal dialysis patients. Int J Artif Organs 2012; 35: 338-345.
31. Davenport A, Sayed RH, Fan S. Is extracellular volume expansion of peritoneal dialysis patients associated with greater urine output? Blood Purif 2011; 32: 226-231.
32. Rocco M, Soucie JM, Pastan S et al. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000; 58: 446-457. (Pubitemid 30429893)
33. Johnson DW, Mudge DW, Sturtevant JM et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 2003; 23: 276-283. (Pubitemid 37045666)
34. Furstenberg A, Davenport A. Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dualenergy x-ray absorptiometry. Am J Nephrol 2011; 33: 150-156.
35. Davenport A, Hussain Sayed R, Fan S. The effect of racial origin on total body water volume in peritoneal dialysis patients. Clin J Am Soc Nephrol 2011; 6: 2492-2498.
36. Davenport A, Willicombe MK. Does diabetes mellitus predispose to increased fluid overload in peritoneal dialysis patients? Nephron Clin Pract 2010; 114: c60-c66.
37. Davenport A, Willicombe MK. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 2009; 4: 1207-1212.
38. John B, Tan BK, Dainty S et al. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2010; 5: 1463-1470.
39. van de Kerkhof J, Hermans M, Beerenhout C et al. Reference values for multifrequency bioimpedance analysis in dialysis patients. Blood Purif 2004; 22: 301-306. (Pubitemid 39177736)
40. White CA, Akbari A. The estimation, measurement, and relevance of the glomerular filtration rate in stage 5 chronic kidney disease. Semin Dial 2011; 24: 540-549.